combination therapy for patients with kidney cancer
Published 2 years ago • 149 plays • Length 1:19Download video MP4
Download video MP3
Similar videos
-
0:58
how can we improve outcomes for patients with kidney cancer who receive immunotherapy?
-
0:48
combining radiotherapy and io for patients with oligometastatic rcc
-
5:18
are combination therapies the future of renal cell carcinoma treatment?
-
1:06
exciting potential of pembrolizumab combined with axitinib for kidney cancer
-
1:31
combining immunotherapy with vegf inhibitors to treat kidney cancer
-
5:11
current treatment landscape for kidney cancer
-
2:02
tki and checkpoint inhibitor combinations for kidney cancer: the immotion151 trial
-
15:25
targeted therapies: the future of non-small cell lung cancer (nsclc) treatment?
-
4:15
the unmet needs of kidney cancer treatment
-
6:22
mtor/tki combination therapy in kidney cancer
-
1:18
using radiotherapy to manage oligometastatic kidney cancer
-
1:02
an expert looks to the future of metastatic kidney cancer treatment
-
21:43
why combination therapy may be best for my kidney cancer elizabeth plimack, md, ms 10/11/19
-
51:09
immunotherapy-based combinations for advanced/metastatic renal cell carcinoma: asco gu 2023
-
7:54
combination therapies in renal cell carcinoma
-
1:39
kidney cancer research: immunotherapy combinations in rare kidney cancers
-
3:30
promising results for axitinib and pembrolizumab in advanced renal cell cancer
-
1:21
enfortumab vedotin and pembrolizumab vs platinum-based combination therapies for patients with muc
-
38:59
new and emerging systemic treatment options for metastatic kidney cancer scott s. tykodi, m.d., phd.